Effect of Dosing Interval on Compliance of Osteoporosis Patients on Bisphosphonate Therapy: Observational Study Using Nationwide Insurance Claims Data
Only a few studies are available on the effect of the dosing interval of bisphosphonate on drug compliance. We analyzed the data of patients who were newly prescribed bisphosphonate using a national insurance claims database. Drug compliance was assessed by calculating medication possession ratio (M...
Main Authors: | Hyunil Lee, Sangcheol Lee, Dokyung Kim, Weonmin Cho, Sungtan Cho, Siyeong Yoon, Soonchul Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/19/4350 |
Similar Items
-
Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern
by: Ko KR, et al.
Published: (2020-10-01) -
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01) -
Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
by: Emily Sunny Lee, et al.
Published: (2023-11-01) -
Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01) -
Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
by: Ahmet Aslan, et al.
Published: (2018-08-01)